152 related articles for article (PubMed ID: 16507219)
1. Phenoxodiol: isoflavone analog with antineoplastic activity.
Choueiri TK; Wesolowski R; Mekhail TM
Curr Oncol Rep; 2006 Mar; 8(2):104-7. PubMed ID: 16507219
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor activity of phenoxodiol: from bench to clinic.
Alvero AB; Kelly M; Rossi P; Leiser A; Brown D; Rutherford T; Mor G
Future Oncol; 2008 Aug; 4(4):475-82. PubMed ID: 18684059
[TBL] [Abstract][Full Text] [Related]
3. Phenoxodiol--an isoflavone analog--induces apoptosis in chemoresistant ovarian cancer cells.
Kamsteeg M; Rutherford T; Sapi E; Hanczaruk B; Shahabi S; Flick M; Brown D; Mor G
Oncogene; 2003 May; 22(17):2611-20. PubMed ID: 12730675
[TBL] [Abstract][Full Text] [Related]
4. Phenoxodiol, a novel approach for the treatment of ovarian cancer.
Mor G; Fu HH; Alvero AB
Curr Opin Investig Drugs; 2006 Jun; 7(6):542-8. PubMed ID: 16784025
[TBL] [Abstract][Full Text] [Related]
5. Phenoxodiol, a novel isoflavone, induces G1 arrest by specific loss in cyclin-dependent kinase 2 activity by p53-independent induction of p21WAF1/CIP1.
Aguero MF; Facchinetti MM; Sheleg Z; Senderowicz AM
Cancer Res; 2005 Apr; 65(8):3364-73. PubMed ID: 15833870
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Therapeutic Potential of Phenoxodiol, a Novel Isoflavone Analog, in Renal Cancer Cells.
Isono M; Sato A; Asano T; Okubo K; Asano T
Anticancer Res; 2018 Oct; 38(10):5709-5716. PubMed ID: 30275191
[TBL] [Abstract][Full Text] [Related]
7. Modulation of apoptosis to reverse chemoresistance.
Mor G; Montagna MK; Alvero AB
Methods Mol Biol; 2008; 414():1-12. PubMed ID: 18175807
[TBL] [Abstract][Full Text] [Related]
8. The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization.
Kluger HM; McCarthy MM; Alvero AB; Sznol M; Ariyan S; Camp RL; Rimm DL; Mor G
J Transl Med; 2007 Jan; 5():6. PubMed ID: 17257402
[TBL] [Abstract][Full Text] [Related]
9. Phenoxodiol: pharmacology and clinical experience in cancer monotherapy and in combination with chemotherapeutic drugs.
Silasi DA; Alvero AB; Rutherford TJ; Brown D; Mor G
Expert Opin Pharmacother; 2009 Apr; 10(6):1059-67. PubMed ID: 19364253
[TBL] [Abstract][Full Text] [Related]
10. The antiproliferative effects of phenoxodiol are associated with inhibition of plasma membrane electron transport in tumour cell lines and primary immune cells.
Herst PM; Petersen T; Jerram P; Baty J; Berridge MV
Biochem Pharmacol; 2007 Dec; 74(11):1587-95. PubMed ID: 17904534
[TBL] [Abstract][Full Text] [Related]
11. Involvement of BH3-only proapoptotic proteins in mitochondrial-dependent Phenoxodiol-induced apoptosis of human melanoma cells.
Yu F; Watts RN; Zhang XD; Borrow JM; Hersey P
Anticancer Drugs; 2006 Nov; 17(10):1151-61. PubMed ID: 17075314
[TBL] [Abstract][Full Text] [Related]
12. Downstream targets of altered sphingolipid metabolism in response to inhibition of ENOX2 by phenoxodiol.
De Luca T; Bosneaga E; Morré DM; Morré DJ
Biofactors; 2008; 34(3):253-60. PubMed ID: 19734127
[TBL] [Abstract][Full Text] [Related]
13. The mechanisms of anticancer agents by genistein and synthetic derivatives of isoflavone.
Li HQ; Luo Y; Qiao CH
Mini Rev Med Chem; 2012 Apr; 12(4):350-62. PubMed ID: 22303948
[TBL] [Abstract][Full Text] [Related]
14. Phenoxodiol Increases Cisplatin Sensitivity in Ovarian Clear Cancer Cells Through XIAP Down-regulation and Autophagy Inhibition.
Miyamoto M; Takano M; Aoyama T; Soyama H; Ishibashi H; Kato K; Iwahashi H; Takasaki K; Kuwahara M; Matuura H; Sakamoto T; Yoshikawa T; Furuya K
Anticancer Res; 2018 Jan; 38(1):301-306. PubMed ID: 29277787
[TBL] [Abstract][Full Text] [Related]
15. Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation.
Kang YC; Kim KM; Lee KS; Namkoong S; Lee SJ; Han JA; Jeoung D; Ha KS; Kwon YG; Kim YM
Cell Death Differ; 2004 Dec; 11(12):1287-98. PubMed ID: 15297884
[TBL] [Abstract][Full Text] [Related]
16. Metabolite modulation of HeLa cell response to ENOX2 inhibitors EGCG and phenoxodiol.
Wu LY; De Luca T; Watanabe T; Morré DM; Morré DJ
Biochim Biophys Acta; 2011 Aug; 1810(8):784-9. PubMed ID: 21571040
[TBL] [Abstract][Full Text] [Related]
17. Phenoxodiol inhibits growth of metastatic prostate cancer cells.
Aguero MF; Venero M; Brown DM; Smulson ME; Espinoza LA
Prostate; 2010 Aug; 70(11):1211-21. PubMed ID: 20564423
[TBL] [Abstract][Full Text] [Related]
18. Topoisomerase inhibitor camptothecin sensitizes mouse hepatocytes in vitro and in vivo to TNF-mediated apoptosis.
Hentze H; Latta M; Künstle G; Dhakshinamoorthy S; Ng PY; Porter AG; Wendel A
Hepatology; 2004 May; 39(5):1311-20. PubMed ID: 15122760
[TBL] [Abstract][Full Text] [Related]
19. Flavonoids, phenoxodiol, and a novel agent, triphendiol, for the treatment of pancreaticobiliary cancers.
Saif MW; Tytler E; Lansigan F; Brown DM; Husband AJ
Expert Opin Investig Drugs; 2009 Apr; 18(4):469-79. PubMed ID: 19278301
[TBL] [Abstract][Full Text] [Related]
20. Phenoxodiol (2H-1-benzopyran-7-0,1,3-(4-hydroxyphenyl)), a novel isoflavone derivative, inhibits DNA topoisomerase II by stabilizing the cleavable complex.
Constantinou AI; Husband A
Anticancer Res; 2002; 22(5):2581-5. PubMed ID: 12529967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
